A non-cell-autonomous role for Pml in the maintenance of leukemia from the niche-Reference-Cited by-同舟云学术

A non-cell-autonomous role for Pml in the maintenance of leukemia from the niche

Published:2018-01-04 Issue:1 Volume:9 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Guarnerio Jlenia,Mendez Lourdes Maria,Asada Noboru,Menon Archita Venugopal,Fung Jacqueline,Berry Kelsey,Frenette Paul S.,Ito Keisuke^ORCID,Pandolfi Pier Paolo^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-017-02427-x.pdf

Reference34 articles.

1. Forman, S. J. & Rowe, J. M. The myth of the second remission of acute leukemia in the adult. Blood 121, 1077–1082 (2013).

2. Huntly, B. J. & Gilliland, D. G. Leukaemia stem cells and the evolution of cancer-stem-cell research. Nat. Rev. Cancer 5, 311–321 (2005).

3. Aoki, Y. et al. Identification of CD34 + and CD34- leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemia. Blood 125, 967–980 (2014).

4. Krivtsov, A. V. et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442, 818–822 (2006).

5. Gibbs, K. D. Jr. et al. Decoupling of tumor-initiating activity from stable immunophenotype in HoxA9-Meis1-driven AML. Cell Stem Cell 10, 210–217 (2012).

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immortalised chronic myeloid leukemia (CML) derived mesenchymal stromal cells (MSCs) line retains the immunomodulatory and chemoprotective properties of CML patient-derived MSCs;Cellular Signalling;2024-04

2. Next generation organoid engineering to replace animals in cancer drug testing;Biochemical Pharmacology;2023-07

3. The PML hub: An emerging actor of leukemia therapies;Journal of Experimental Medicine;2023-06-29

4. High Throughput Fluorescence-Based In Vitro Experimental Platform for the Identification of Effective Therapies to Overcome Tumour Microenvironment-Mediated Drug Resistance in AML;Cancers;2023-03-27

5. In the Pipeline: Emerging Therapy for CML;Pathogenesis and Treatment of Leukemia;2023